Last Updated:
10 Mar 2026, 03:30:03 PM (IST)
Sakar Healthcare Limited
NSE: SAKAR
NSE
538.60
15.20 (2.90%)
Prev Close
523.4
Open Price
535
Volume
124,706
Today Low / High
527.05 / 557
52 WK Low / High
210.1 / 569.95
Range
512 - 566
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 538.6, with a change of 15.2 (2.90409%). The expected target range on the NSE is between 512 - 566. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Sakar Healthcare Limited Graph
Sakar Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sakar Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 538.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 538.60 | 543.99 | 489.59 - 598.38 |
| 549.37 | 439.50 - 659.25 | ||
| 554.76 | 388.33 - 721.19 | ||
| Bearish Scenario | 538.60 | 533.21 | 479.89 - 586.54 |
| 527.83 | 422.26 - 633.39 | ||
| 522.44 | 365.71 - 679.17 |
Overview of Sakar Healthcare Limited
ISIN
INE732S01012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
79,202
Market Cap
11,288,838,713
Last Dividend
0
Official Website
IPO Date
2017-03-16
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 177.58 Cr | 134.79 Cr | 42.79 Cr | 0.2410 | 0.22 Cr | 2.10 Cr | 28.80 Cr | 17.50 Cr | 8.03 | 50.94 Cr | 0.0986 |
| 2024-03-31 | 154.17 Cr | 84.21 Cr | 69.96 Cr | 0.4538 | 0.55 Cr | 19.78 Cr | 49.55 Cr | 11.67 Cr | 5.69 | 39.33 Cr | 0.0757 |
| 2023-03-31 | 133.36 Cr | 73.55 Cr | 59.81 Cr | 0.4485 | 0.72 Cr | 1.19 Cr | 18.46 Cr | 12.76 Cr | 6.86 | 37.81 Cr | 0.0957 |
| 2022-03-31 | 128.23 Cr | 74.81 Cr | 53.41 Cr | 0.4165 | 0.11 Cr | 0.70 Cr | 38.89 Cr | 15.24 Cr | 10.09 | 31.57 Cr | 0.1189 |
| 2021-03-31 | 94.74 Cr | 51.49 Cr | 43.25 Cr | 0.4565 | 0.01 Cr | 0.73 Cr | 14.97 Cr | 10.68 Cr | 7.09 | 23.77 Cr | 0.1128 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.31 Cr | 415.26 Cr | 129.79 Cr | 285.4759 Cr | 74.95 Cr | 74.65 Cr | 43.59 Cr | 321.05 Cr | 0.00 Cr | 0.00 Cr | 0.30 Cr | 63.1861 Cr |
| 2024-03-31 | 0.26 Cr | 388.66 Cr | 126.33 Cr | 262.3311 Cr | 79.35 Cr | 79.09 Cr | 28.06 Cr | 315.28 Cr | 0.00 Cr | -16.56 Cr | 0.30 Cr | 59.0603 Cr |
| 2023-03-31 | 0.09 Cr | 336.34 Cr | 162.99 Cr | 173.3471 Cr | 119.18 Cr | 111.15 Cr | 15.40 Cr | 273.09 Cr | 9.74 Cr | 1.70 Cr | 0.30 Cr | 54.4918 Cr |
| 2022-03-31 | 0.03 Cr | 267.76 Cr | 140.30 Cr | 127.4646 Cr | 92.86 Cr | 92.83 Cr | 14.18 Cr | 216.93 Cr | 5.41 Cr | 86.45 Cr | 0.81 Cr | 46.7623 Cr |
| 2021-03-31 | 0.08 Cr | 177.79 Cr | 79.34 Cr | 98.4522 Cr | 42.60 Cr | 42.51 Cr | 15.70 Cr | 142.52 Cr | 7.13 Cr | 0.00 Cr | -0.67 Cr | 33.2691 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 34.0320 Cr | -30.7092 Cr | -3.4792 Cr | -13.5518 Cr | -0.1563 Cr | 0.3093 Cr | -32.2826 Cr | 17.5020 Cr | 6.1198 Cr | 0.0000 Cr | -15.8600 Cr |
| 2024-03-31 | 24.4669 Cr | -51.5392 Cr | 27.4447 Cr | -35.0933 Cr | 0.3723 Cr | 0.4656 Cr | -59.5602 Cr | 11.6709 Cr | -43.2730 Cr | 0.0000 Cr | -12.3348 Cr |
| 2023-03-31 | 35.3141 Cr | -74.3766 Cr | 41.0960 Cr | -46.8811 Cr | 0.0634 Cr | 0.0933 Cr | -82.1952 Cr | 16.8761 Cr | 13.2208 Cr | 0.0000 Cr | -1.2141 Cr |
| 2022-03-31 | 35.6986 Cr | -90.3724 Cr | 32.0332 Cr | -61.8326 Cr | -0.0526 Cr | 0.0299 Cr | -97.5312 Cr | 18.9321 Cr | 26.0539 Cr | 0.0000 Cr | 1.5139 Cr |
| 2021-03-31 | 14.5767 Cr | -46.8334 Cr | 32.0332 Cr | -20.9689 Cr | -0.2235 Cr | 0.0825 Cr | -35.5457 Cr | 13.2327 Cr | 26.0539 Cr | 0.0000 Cr | -4.7640 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 70.34 Cr | 51.80 Cr | 18.55 Cr | 0.2636 | 12.22 Cr | 10.25 Cr | 4.61 | 19.10 Cr | 0.1457 |
| 2025-09-30 | 57.56 Cr | 44.43 Cr | 13.13 Cr | 0.2281 | 5.67 Cr | 4.54 Cr | 2.04 | 12.57 Cr | 0.0789 |
| 2025-06-30 | 52.74 Cr | 28.95 Cr | 23.78 Cr | 0.4510 | 7.13 Cr | 4.67 Cr | 2.11 | 13.10 Cr | 0.0886 |
| 2025-03-31 | 50.24 Cr | 36.04 Cr | 14.21 Cr | 0.2827 | 10.25 Cr | 5.76 Cr | 2.64 | 15.91 Cr | 0.1147 |
| 2024-12-31 | 43.42 Cr | 22.63 Cr | 20.78 Cr | 0.4787 | 6.53 Cr | 4.53 Cr | 2.08 | 12.00 Cr | 0.1044 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.01 Cr | 0.21 Cr | 0.22 Cr | 31.99 Cr | 44.53 Cr | 94.63 Cr | 334.15 Cr | 448.60 Cr | 145.34 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 0.31 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -285.48 Cr |
| 2025-03-31 | 0.31 Cr | 0.00 Cr | 0.31 Cr | 30.72 Cr | 43.59 Cr | 88.73 Cr | 321.05 Cr | 415.26 Cr | 129.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -269.43 Cr |
| 2024-09-30 | 0.32 Cr | 0.21 Cr | 0.53 Cr | 24.02 Cr | 33.86 Cr | 80.45 Cr | 314.16 Cr | 404.24 Cr | 134.81 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 4.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 5.76 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 4.53 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 4.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
MD & Executive Director
Aarsh Sanjay Shah
Gender: male
Year Born: 1991
Company Secretary & Compliance Officer
Bharat S. Soni
Gender: male
Year Born: 1990
Chief Financial Officer
Dharmesh R. Thaker
Gender: male
Year Born:
Senior Vice President of International Business
Nimesh Suthar
Gender: male
Year Born:
Senior Vice President of Finance & Accounts
Raviraj Kariaas
Gender: male
Year Born:
Chairman & MD
Sanjay Surendra Shah
Gender: male
Year Born: 1959
Chief Operating Officer
Sudhir Ghuleas
Gender: male
Year Born:
Technical Director
Sunil Vasantrao Marathe
Gender: male
Year Born: 1970
FAQs about Sakar Healthcare Limited
Who is the CEO of the company?
The CEO is Sanjay Surendra Shah.
What is the current market price of the stock?
The current price is ₹514.30.
What is the 52-week price range?
The range is ₹210.1-569.95.
What is the market capitalization of the company?
The market capitalization is ₹1,128.88 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 45.37.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Sakar Healthcare Limited (ISIN: INE732S01012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹1,128.88 crores and an average daily volume of 79,202 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.